RNAZ
Transcode Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
—
Transcode Therapeutics, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
—
1.59
+0.02 · +1.27%
post 1.59 0.00%
−27.37%
shares held · 6 largest managers
No reported quarters.
No open-interest data.
No filed income statement.
Bar = avg |move| to ±7% · tick = ±6.5% avg day · ×base = |move| ÷ ±6.5% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -7.17 | — |
| Q1 FY26 | — | -21.28 | — |
| Q3 FY25 | — | -5.82 | — |
Source: filed financials
Expected move
No implied move.
No linked exposure.